Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16620141 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Intervention: Drug: Rituximab

Indicates status has not been verified in more than two years